<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32388880</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1529-8027</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the peripheral nervous system : JPNS</Title>
          <ISOAbbreviation>J Peripher Nerv Syst</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.</ArticleTitle>
        <Pagination>
          <StartPage>204</StartPage>
          <EndPage>207</EndPage>
          <MedlinePgn>204-207</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jns.12382</ELocationID>
        <Abstract>
          <AbstractText>Acute demyelinating inflammatory polyneuropathy (AIDP) is the most common type of Guillain-Barré syndrome (GBS) in Europe, following several viral and bacterial infections. Data on AIDP-patients associated with SARS-CoV-2 (coronavirus-2) infection are scarce. We describe the case of a 54-years-old Caucasian female patient with typical clinical and electrophysiological manifestations of AIDP, who was reported positive with PCR for SARS-CoV-2, 3 weeks prior to onset of the neurological symptoms. She did not experience a preceding fever or respiratory symptoms, but a transient loss of smell and taste. At the admission to our neurological department, a progressive proximally pronounced paraparesis, areflexia, and sensory loss with tingling of all extremities were found, which began 10 days before. The modified Erasmus Giullain-Barré Syndrome outcome score (mEGOS) was 3/9 at admission and 1/12 at day 7 of hospitalization. The electrophysiological assessment proved a segmental demyelinating polyneuropathy and cerebrospinal fluid examination showed an albuminocytologic dissociation. The neurological symptoms improved significantly during treatment with immunoglobulins. Our case draws attention to the occurrence of GBS also in patients with COVID-19 (coronavirus disease 2019), who did not experience respiratory or general symptoms. It emphasizes that SARS-CoV-2 induces immunological processes, regardless from the lack of prodromic symptoms. However, it is likely that there is a connection between the severity of the respiratory syndrome and further neurological consequences.</AbstractText>
          <CopyrightInformation>© 2020 Peripheral Nerve Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Scheidl</LastName>
            <ForeName>Erika</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-5553-3061</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Dierdorf-Selters, Selters, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Canseco</LastName>
            <ForeName>Daniel Diez</ForeName>
            <Initials>DD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Dierdorf-Selters, Selters, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hadji-Naumov</LastName>
            <ForeName>Aleksandar</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Dierdorf-Selters, Selters, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bereznai</LastName>
            <ForeName>Benjamin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hospital Dierdorf-Selters, Selters, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>05</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Peripher Nerv Syst</MedlineTA>
        <NlmUniqueID>9704532</NlmUniqueID>
        <ISSNLinking>1085-9489</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000370" MajorTopicYN="N">Ageusia</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009431" MajorTopicYN="N">Neural Conduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">COVID-19</Keyword>
        <Keyword MajorTopicYN="Y">Guillain-Barré syndrome</Keyword>
        <Keyword MajorTopicYN="Y">SARS-CoV2</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32388880</ArticleId>
        <ArticleId IdType="pmc">PMC7273104</ArticleId>
        <ArticleId IdType="doi">10.1111/jns.12382</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Carod‐Artal FJ. Neurological complications of coronavirus and COVID‐19. Rev Neurol. 2020;70(9):311‐322. 10.33588/rn.7009.2020179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.33588/rn.7009.2020179</ArticleId>
            <ArticleId IdType="pubmed">32329044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Helm J, Kremer S, Merdji H, et al. Neurologic features in severe SARS‐CoV‐2 infection. N Engl J Med. 2020; NEJMc2008597. 10.1056/NEJMc2008597. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId>
            <ArticleId IdType="pmc">PMC7179967</ArticleId>
            <ArticleId IdType="pubmed">32294339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Willison HJ, Jacobs BC, van Doorn PA. Giullain‐Barre syndrome. Lancet. 2016;V338(10045):P717‐P727. 10.1016/S0140-6736(16)00339-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00339-1</ArticleId>
            <ArticleId IdType="pubmed">26948435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Toscano G, Palmerini F, Ravaglia S, et al. Guillain–Barré syndrome associated with SARS‐CoV‐2. N Engl J Med. 2020. 
10.1056/NEJMc2009191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId>
            <ArticleId IdType="pmc">PMC7182017</ArticleId>
            <ArticleId IdType="pubmed">32302082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sedaghat Z, Karimi N. Guillain‐Barre syndrome associated with COVID‐19 infection: a case report. J Clin Neurosci. 2020.  pii: S0967‐5868(20)30882‐1. 10.1016/j.jocn.2020.04.062 [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId>
            <ArticleId IdType="pmc">PMC7158817</ArticleId>
            <ArticleId IdType="pubmed">32312628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Camdessanche J, Morel J, Pozzetto B, et al. COVID‐19 may induce Guillain‐Barré syndrome. Rev Neurol (Paris). 2020. 
10.1016/j.neurol.2020.04.003 [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurol.2020.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC7158797</ArticleId>
            <ArticleId IdType="pubmed">32334841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Padroni M, Mastrangelo V, Asioli GM, et al. Guillain‐Barré syndrome following COVID‐19: new infection, old complication?
J Neurol. 2020;24
10.1007/s00415-020-09849-6 [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09849-6</ArticleId>
            <ArticleId IdType="pmc">PMC7180646</ArticleId>
            <ArticleId IdType="pubmed">32333166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Virani A, Rabold E, Hanson T, et al. Guillain‐Barré syndrome associated with SARS‐CoV‐2 infection. IDCases. 2020;20:e00771
10.1016/j.idcr.2020.e00771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idcr.2020.e00771</ArticleId>
            <ArticleId IdType="pmc">PMC7165113</ArticleId>
            <ArticleId IdType="pubmed">32313807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gutierrez‐Ortiz C, Mendez A, Rodrigo‐Rey S, et al. Miller‐Fisher syndrome and polyneuritis cranialis in COVID‐19. Neurology. 2020;pii:10.1212/WNL.0000000000009619. 10.1212/WNL.0000000000009619 [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009619</ArticleId>
            <ArticleId IdType="pubmed">32303650</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
